NCT04599738

Brief Summary

Millet is a functional grain that has attracted the attention of scientists for many years due to its significant benefits to human health. Research has shown that millets have a high antioxidant capacity and polyphenol content which can contribute to a reduced risk of some chronic diseases such as type 2 diabetes and its complications. This study aimed to assess the glycaemic response (GR), insulinaemic response (IR) and gastric emptying (GE) after the consumption of millet-based muffins in pre-diabetic and healthy participants. This was a single-blind, randomized controlled crossover study in which participants consumed one control muffin (wheat) and one test muffin (millet). During each session, participants were required to consume either the test or the control muffin, consuming the alternative on the next visit. Then, 10 finger-prick blood samples were taken for the determination of glucose and insulin over 4 hours. 13Carbon (13C) sodium acetate was added to the muffins (control and test) in order to measure gastric emptying from the breath samples collected.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 6, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 24, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 24, 2017

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

October 11, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 23, 2020

Completed
Last Updated

October 23, 2020

Status Verified

October 1, 2020

Enrollment Period

10 months

First QC Date

October 11, 2020

Last Update Submit

October 17, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in glycaemic response from baseline for 180 minutes

    Capillary blood glucose was measured for 180 minutes at 0, 15, 30, 45, 60, 90, 120, 150 and 180 minutes

    180 minutes

  • Change in insulin response from baseline for 180 minutes

    Capillary plasma insulin was measured for 180 minutes at 0, 15, 30, 45, 60, 90, 120, 150 and 180 minutes

    180 minutes

Secondary Outcomes (2)

  • Gastric emptying for 4 hours

    4 hours

  • Satiety by visual analogue scale for 4 hours

    4hours

Study Arms (2)

Wheat muffin

PLACEBO COMPARATOR

Muffin made with 100% wheat flour

Other: Wheat muffin

Finger millet grain muffin

EXPERIMENTAL

Muffin made with 50% wheat flour and 50% finger millet crushed grain

Other: Finger millet grain muffin

Interventions

Participants consumed a control muffin made of wheat flour.

Wheat muffin

Participants consumed a test muffin made of finger millet grain and wheat flour.

Finger millet grain muffin

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • for healthy participants
  • Aged 18-65 years
  • Body mass index (BMI) ≤ 30kg/m2
  • Fasting blood glucose \< 6.1 mmol/l
  • Non-pregnant and non-lactating
  • No known diabetes or impaired glucose tolerance
  • No medical condition(s) or medication(s) known to affect glucose regulation or appetite and/or which influence digestion and absorption of nutrients
  • No major medical or surgical event requiring hospitalisation within the preceding three months
  • No use of steroids, protease inhibitors or antipsychotics
  • No food allergy to millet, wheat, egg and milk.
  • At least one of the following for pre-diabetes participants Fasting blood glucose 6.1-6.9 mmol/l (108-125 mg/ dI) - (WHO, 2006) or/and an Oral glucose tolerance test (OGTT) at 2 hours 7.9 to 11.0 mmol/l

You may not qualify if:

  • Pregnant and lactating
  • Diabetes
  • Medical condition(s) or medication(s) known to affect glucose regulation or appetite and/or which influence digestion and absorption of nutrients
  • Medical or surgical event requiring hospitalisation within the preceding three months
  • Use of steroids, protease inhibitors or antipsychotics (because of their effects on glucose regulation of appetite or influence digestion and absorption of nutrients).
  • Food allergy to study products (millet. wheat, egg, milk, butter, sugar).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oxford Brookes Centre for Nutrition and Health

Oxford, OX3 0BP, United Kingdom

Location

Related Publications (2)

  • Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G, Wolever TM. Glycaemic index methodology. Nutr Res Rev. 2005 Jun;18(1):145-71. doi: 10.1079/NRR2005100.

    PMID: 19079901BACKGROUND
  • Carbohydrates in human nutrition. Report of a Joint FAO/WHO Expert Consultation. FAO Food Nutr Pap. 1998;66:1-140. No abstract available.

    PMID: 9743703BACKGROUND

Related Links

MeSH Terms

Conditions

Glucose Intolerance

Condition Hierarchy (Ancestors)

HyperglycemiaGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Sangeetha Thondre

    Oxford Brookes University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer

Study Record Dates

First Submitted

October 11, 2020

First Posted

October 23, 2020

Study Start

March 6, 2017

Primary Completion

December 24, 2017

Study Completion

December 24, 2017

Last Updated

October 23, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Immediately following registration
Access Criteria
Upon request

Available IPD Datasets

Study Protocol Access
Informed Consent Form Access

Locations